By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
INTRODUCTION
Methocarbamol, sold under the brand name Robaxin among others, is a medication used for short-term musculoskeletal pain. It may be used together with rest, physical therapy, and pain medication. It is less preferred in low back pain. It has limited use for rheumatoid arthritis and cerebral palsy. Effects generally begin within half an hour.It is taken by mouth or injection into a vein.
Common side effect include headaches, sleepiness, and dizziness. Serious side effects may include anaphylaxis, liver problems, confusion, and seizures. Use is not recommended in pregnancy and breastfeeding. Because of risk of injury, skeletal muscle relaxants should generally be avoided in geriatric patients.
Methocarbamol is a centrally acting muscle relaxant. How it works is unclear, but it does not appear to affect muscles directly. Methocarbamol was developed in the laboratories of A. H. Robins (later acquired by Pfizer).
Studies were directed towards the development of propanediol derivatives which possessed muscle relaxant properties superior to those of morpheein, which had low potency and a short duration of action. The clinical effectiveness of methocarbamol compared to other muscle relaxants is not well-known.
One trial of methocarbamol versus cyclobenzaprine, a well-studied muscle relaxant, in those with localized muscle spasm found there was no significant differences in their effects on improved muscle spasm, limitation of motion, or limitation of daily activities.
METHOCARBAMOL MARKET SIZE AND FORECAST
The Global Methocarbamol market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
METHOCARBAMOL MARKET NEW PRODUCT LAUNCH
AURO PHARMA Methocarbamol METHOCARBAMOL belongs to the group of medicines called ‘muscle relaxants’. It is mainly used to relieve pain and muscle spasms occurring due to acute musculoskeletal problems.
Muscle spasm is the painful and involuntary contraction that occurs when the nerve impulses that control the muscle movements are damaged or interrupted. Secondly, it also treats tetanus conditions (lockjaw) which are characterized by painful tightening of muscles. Tetanus is a nerve disorder leading to painful muscle contraction, mainly affecting the jaw and neck muscles.
METHOCARBAMOL consists of methocarbamol. It works by blocking pain impulses sent to the spinal cord and brain, thereby helps to maintain muscle strength and relieving muscle spasms or stiffness.
METHOCARBAMOL MARKET COMPANY PROFILE
THIS METHOCARBAMOL MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS
